Baird Financial Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-36,747
| Closed | -$1.76M | – | 1589 |
|
|
2020
Q2 | $1.76M | Buy |
36,747
+910
| +3% | +$43.7K | 0.01% | 759 |
|
|
2020
Q1 | $1.65M | Buy |
35,837
+88
| +0.2% | +$4.05K | 0.01% | 744 |
|
|
2019
Q4 | $2.15M | Buy |
35,749
+4,107
| +13% | +$247K | 0.01% | 755 |
|
|
2019
Q3 | $1.79M | Buy |
31,642
+1,210
| +4% | +$68.5K | 0.01% | 806 |
|
|
2019
Q2 | $1.7M | Sell |
30,432
-1,653
| -5% | -$92.1K | 0.01% | 830 |
|
|
2019
Q1 | $1.62M | Sell |
32,085
-2,079
| -6% | -$105K | 0.01% | 729 |
|
|
2018
Q4 | $1.38M | Sell |
34,164
-87
| -0.3% | -$3.5K | 0.01% | 721 |
|
|
2018
Q3 | $2.32M | Buy |
34,251
+489
| +1% | +$33.1K | 0.01% | 623 |
|
|
2018
Q2 | $2.55M | Buy |
33,762
+44
| +0.1% | +$3.33K | 0.02% | 599 |
|
|
2018
Q1 | $1.78M | Buy |
33,718
+105
| +0.3% | +$5.53K | 0.01% | 663 |
|
|
2017
Q4 | $1.8M | Sell |
33,613
-104
| -0.3% | -$5.56K | 0.01% | 660 |
|
|
2017
Q3 | $2.01M | Sell |
33,717
-170
| -0.5% | -$10.1K | 0.02% | 617 |
|
|
2017
Q2 | $2.67M | Sell |
33,887
-86
| -0.3% | -$6.78K | 0.02% | 532 |
|
|
2017
Q1 | $2.82M | Buy |
33,973
+451
| +1% | +$37.4K | 0.02% | 516 |
|
|
2016
Q4 | $2.66M | Buy |
+33,522
| New | +$2.66M | 0.02% | 508 |
|